Margaret Koziel Email

VP Clinical Development . Axcella

Current Roles

Employees:
27
Revenue:
$13.5M
About
Axcella is designing and developing novel endogenous metabolic modulator compositions to safely reprogram metabolic dysregulation. We are transforming the discovery and development of traditional drug and consumer health candidates from concept to clinical stages, by leveraging our deep understanding of human biology. Our novel approach rapidly gains unprecedented information in a capital efficient manner. Our platform has already produced a rich pipeline of product candidates in programs targeting liver, muscle, and CNS. Axcella Health was founded by Flagship Pioneering.
Axcella Address
840 Memorial Drive
Cambridge, MA
United States

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.